Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Laurus Labs Ltd (LAUL)
Track today's live Laurus Labs (LAUL) share price, performance and key data on this page with our current NSE:LAUL stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Laurus Labs share price on the NSE exchange. Use the dropdown to switch exchange for the LAUL share price, head to our technical summary section, which provides analysis on Laurus Labs share price buy/sell indicators using real-time data (or discuss the Laurus Labs (LAUL) stock price today with other investors in the Laurus Labs NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:LAUL share price (ISIN: INE947Q01028) to enhance your trading decisions with our free investment tools and resources.
What Is the Laurus Labs Ltd Share Price Today?
The Laurus Labs share price today is 1,503.10.
What Is the Stock Symbol for Laurus Labs Ltd
The stock symbol (or 'ticker') for Laurus Labs Ltd is "LAUL."
What Stock Exchange Does Laurus Labs Ltd Trade On?
Laurus Labs Ltd is listed and trades on the NSE stock exchange.
Is Laurus Labs Ltd a Good Stock to Buy?
Determining whether Laurus Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:LAUL share price (ISIN: INE947Q01028) to enhance your trading decisions with our free investment tools and resources.
What Is the Laurus Labs Ltd Share Price Today?
The Laurus Labs share price today is 1,503.10.
What Is the Stock Symbol for Laurus Labs Ltd
The stock symbol (or 'ticker') for Laurus Labs Ltd is "LAUL."
What Stock Exchange Does Laurus Labs Ltd Trade On?
Laurus Labs Ltd is listed and trades on the NSE stock exchange.
Is Laurus Labs Ltd a Good Stock to Buy?
Determining whether Laurus Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
1,495.70
-33.50(-2.19%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,494.30
1,533.70
52 wk Range
761.20
1,555.00
LAUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,494.301,533.70
52 wk Range
761.201,555.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.13%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.13%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LAUL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
1,055.15
Downside
-29.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
6 Buy
2 Hold
5 Sell
Ratings:
13 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1,055.15
(-29.45% Downside)
Earnings
Latest Release
30/04/2026
EPS / Forecast
5.20 / 5.06
Revenue / Forecast
18.12B / 18.96B
Compare LAUL to Peers and Sector
Metrics to compare | LAUL | Peers Peers - average of corresponding metrics from companies closely matching LAUL: DIVISLAB, SHILPAMED, SMSPHARMA, SAILIFE, NEULANDLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLAULPeersSector |
|---|---|---|---|---|
P/E Ratio | 92.9x | 35.6x | −0.4x | |
PEG Ratio | 0.63 | 1.58 | 0.00 | |
Price/Book | 15.6x | 5.0x | 2.6x | |
Price / LTM Sales | 12.1x | 4.3x | 3.1x | |
Upside (Analyst Target) | −26.1% | 0.3% | 48.3% | |
Fair Value Upside | Unlock | −2.6% | 6.1% | Unlock |
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also provides biotechnology services that develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company also offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Laurus Labs (NSE: LAUL) Share Price Today?
The Laurus Labs stock price today is 1,495.70 INR.
What Stock Exchange Does Laurus Labs (LAUL) Trade On?
Laurus Labs is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Laurus Labs?
The stock symbol (also called a 'ticker') for Laurus Labs is "LAUL."
Does Laurus Labs Pay Dividends? What’s The Current LAUL Dividend Yield?
Yes, LAUL Pays Dividends to its Shareholders. The current Laurus Labs dividend yield is 0.13%.
What Is the Current Laurus Labs Market Capitalisation?
As of today, Laurus Labs (NSE: LAUL) market cap is 811.46B INR.
What Is Laurus Labs's (LAUL) Earnings Per Share (TTM)?
The Laurus Labs EPS is currently 16.45 (Trailing Twelve Months).
When Is the Next Laurus Labs Earnings Date?
Laurus Labs's next earnings report will be released on 23/07/2026.
Is LAUL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Laurus Labs moving averages and other technical indicators, the daily buy/sell signal for LAUL stock is Strong Buy.
How Many Times Has Laurus Labs Stock Split?
Laurus Labs has split 1 times. (See the LAUL stock split history page for full effective split date and price information.)
How Many Employees Does Laurus Labs Have?
Laurus Labs has 7059 employees, based on their latest Companies House report.
What is the current trading status of Laurus Labs (NSE: LAUL)?
As of 07/07/2026, Laurus Labs (LAUL) is trading at a share price of 1,495.70 INR, with a previous close of 1,529.20 INR. The stock has fluctuated within a day range of 1,494.30 INR to 1,533.70 INR, while its 52-week range spans from 761.20 INR to 1,555.00 INR.
What Is Laurus Labs (LAUL) Price Target According to Analysts?
The average 12-month price target for Laurus Labs is 1,055.15 INR, with a high estimate of 1370 INR and a low estimate of 510 INR. 6 analysts recommend buying the stock, while 5 suggest selling, leading to an overall rating of Neutral. The stock has an -29.45% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.